Literature DB >> 12528909

Graft selection in anterior cruciate ligament reconstruction.

Suzanne L Miller1, James N Gladstone.   

Abstract

Selecting the appropriate graft for ACL reconstruction depends on numerous factors including surgeon philosophy and experience, tissue availability (affected by anatomical anomalies or prior injury or surgery), and patient activity level and desires. Although the patella tendon autograft has the widest experience in the literature, and is probably the most commonly used graft source, this must be tempered with the higher reported incidences of potential morbidity and pitfalls associated with its use. The hamstring tendons are gaining increasing popularity, mostly due to reduced harvest morbidity and improved soft tissue fixation techniques, and many recent studies in the literature report equal results to BTB ACL reconstruction with respect to functional outcome and patient satisfaction. On the other hand, many of these studies report higher degrees of instrument (KT-100) tested laxity for hamstring reconstruction, and some have reported lower returns to preinjury levels of activity. One question that remains to be addressed is how closely objectively measured laxity tests correlate with subjectively assessed outcomes and ability to return to high levels of competitive sports. Allograft use, which decreased in popularity during the 1990s, appears to be undergoing a resurgence, with better sterilization processes and new graft sources (tibialis tendons), leading to increased availability and improved fixation techniques. The benefits of decreased surgical morbidity and easier rehabilitation must be weighed against the potential for greater failure of biologic incorporation, infection, and possibly slower return to activities. In our practice, for high-demand individuals (those playing cutting, pivoting, or jumping sports and skiing) BTB tends to be the graft of choice. For lower demand or older individuals, hamstring reconstructions will be performed. Allograft tissue will be used in older individuals (generally over 45 years old), those with signs of arthritis (and compelling evidence of instability), or those individuals who understand the pros and cons of allograft use fully and do not want their own tissue used.

Entities:  

Mesh:

Year:  2002        PMID: 12528909     DOI: 10.1016/s0030-5898(02)00027-5

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  26 in total

1.  Peripheral blood mononuclear cells enhance the anabolic effects of platelet-rich plasma on anterior cruciate ligament fibroblasts.

Authors:  Ryu Yoshida; Martha M Murray
Journal:  J Orthop Res       Date:  2012-07-05       Impact factor: 3.494

2.  Comparison of clinical outcomes and second-look arthroscopic findings after ACL reconstruction using a hamstring autograft or a tibialis allograft.

Authors:  Seung-Hyun Yoo; Eun-Kyoo Song; Young-Rok Shin; Sung-Kyu Kim; Jong-Keun Seon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-30       Impact factor: 4.342

Review 3.  Graft healing in anterior cruciate ligament reconstruction.

Authors:  Max Ekdahl; James H-C Wang; Mario Ronga; Freddie H Fu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-07-17       Impact factor: 4.342

4.  Anterior cruciate ligament reconstruction with LARS™ artificial ligament results at a mean follow-up of eight years.

Authors:  Paolo Domenico Parchi; Ciapini Gianluca; Lorenzo Dolfi; Alessandro Baluganti; Piolanti Nicola; Fabio Chiellini; Michele Lisanti
Journal:  Int Orthop       Date:  2013-06-29       Impact factor: 3.075

5.  Increasing platelet concentration in platelet-rich plasma inhibits anterior cruciate ligament cell function in three-dimensional culture.

Authors:  Ryu Yoshida; Mingyu Cheng; Martha M Murray
Journal:  J Orthop Res       Date:  2013-10-04       Impact factor: 3.494

6.  Prospective comparison of auto and allograft hamstring tendon constructs for ACL reconstruction.

Authors:  Cory M Edgar; Scott Zimmer; Sanjeev Kakar; Hugh Jones; Anthony A Schepsis
Journal:  Clin Orthop Relat Res       Date:  2008-06-25       Impact factor: 4.176

7.  Age over 50 years is not a contraindication for anterior cruciate ligament reconstruction.

Authors:  Giuseppe Gianluca Costa; Alberto Grassi; Simone Perelli; Giuseppe Agrò; Federico Bozzi; Mirco Lo Presti; Stefano Zaffagnini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-04-03       Impact factor: 4.342

8.  Arthroscopic anatomic double-bundle ACL reconstruction using irradiated versus non-irradiated hamstring tendon allograft.

Authors:  Shaoqi Tian; Chengzhi Ha; Bin Wang; Yuanhe Wang; Lun Liu; Qicai Li; Xu Yang; Kang Sun
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-05-07       Impact factor: 4.342

9.  Decellularization of bovine anterior cruciate ligament tissues minimizes immunogenic reactions to alpha-gal epitopes by human peripheral blood mononuclear cells.

Authors:  Ryu Yoshida; Patrick Vavken; Martha M Murray
Journal:  Knee       Date:  2011-09-16       Impact factor: 2.199

10.  Ankle morbidity after autogenous Achilles tendon harvesting for anterior cruciate ligament reconstruction.

Authors:  Jai Gon Seo; Jae Chul Yoo; Young Wan Moon; Moon Jong Chang; Jong Won Kwon; Jong Hyun Kim; Mu Hyun Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-02-13       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.